ask="N/A"
ask_size="N/A"
average_daily_volume="30305"
bid="3.12"
bid_size="100"
book_value="3.34"
change="-0.62"
change_from_200_day_moving_average="5.11"
change_from_50_day_moving_average="2.84"
change_from_52_week_high="-0.75"
change_From_52_week_low="8.48"
change_in_percent="-4.91%"
close="12.00"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.26"
ebitda="-50.28M"
eps_estimate_current_year="-2.54"
eps_estimate_next_quarter="-0.60"
eps_estimate_next_year="-2.57"
ex_dividend_date="N/A"
float_shares="N/A"
high="12.50"
high_52_weeks="12.75"
last_trade_date="3/3/2017"
last_trade_price="12.00"
last_trade_size="150"
last_trade_time="3:59pm"
low="11.16"
low_52_weeks="3.52"
market_capitalization="255.36M"
moving_average_200_day="6.89"
moving_average_50_day="9.16"
name="Nabriva Therapeutics AG"
notes="N/A"
one_year_target_price="15.81"
open="12.50"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+74.06%"
percent_change_from_50_day_moving_average="+31.05%"
percent_change_from_52_week_high="-5.88%"
percent_change_from_52_week_low="+240.91%"
previous_close="12.62"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="3.78"
price_per_sales="51.64"
revenue="5.20M"
shares_outstanding="21280000"
short_ratio="3.79"
stock_exchange="NMS"
symbol="NBRV"
volume="28518"
weeks_range_52="3.52 - 12.75"
